Managing Specialty Drug Use and Cost
Pinscriptive CEO Mark Lelinski and CTO Roni Amiel Published in CIO Review Stop the madness! There’s got to be a better way, right? Specialty drugs account for just 2% of all medicines prescribed, yet they are on pace to comprise 50% of the drug spend in the next few years – ballooning to $400B inRead more